[HTML][HTML] Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay

GM Laird, EE Eisele, SA Rabi, J Lai, S Chioma… - PLoS …, 2013 - journals.plos.org
GM Laird, EE Eisele, SA Rabi, J Lai, S Chioma, JN Blankson, JD Siliciano, RF Siliciano
PLoS pathogens, 2013journals.plos.org
HIV-1 persists in infected individuals in a stable pool of resting CD4+ T cells as a latent but
replication-competent provirus. This latent reservoir is the major barrier to the eradication of
HIV-1. Clinical trials are currently underway investigating the effects of latency-disrupting
compounds on the persistence of the latent reservoir in infected individuals. To accurately
assess the effects of such compounds, accurate assays to measure the frequency of latently
infected cells are essential. The development of a simpler assay for the latent reservoir has …
HIV-1 persists in infected individuals in a stable pool of resting CD4+ T cells as a latent but replication-competent provirus. This latent reservoir is the major barrier to the eradication of HIV-1. Clinical trials are currently underway investigating the effects of latency-disrupting compounds on the persistence of the latent reservoir in infected individuals. To accurately assess the effects of such compounds, accurate assays to measure the frequency of latently infected cells are essential. The development of a simpler assay for the latent reservoir has been identified as a major AIDS research priority. We report here the development and validation of a rapid viral outgrowth assay that quantifies the frequency of cells that can release replication-competent virus following cellular activation. This new assay utilizes bead and column-based purification of resting CD4+ T cells from the peripheral blood of HIV-1 infected patients rather than cell sorting to obtain comparable resting CD4+ T cell purity. This new assay also utilizes the MOLT-4/CCR5 cell line for viral expansion, producing statistically comparable measurements of the frequency of latent HIV-1 infection. Finally, this new assay employs a novel quantitative RT-PCR specific for polyadenylated HIV-1 RNA for virus detection, which we demonstrate is a more sensitive and cost-effective method to detect HIV-1 replication than expensive commercial ELISA detection methods. The reductions in both labor and cost make this assay suitable for quantifying the frequency of latently infected cells in clinical trials of HIV-1 eradication strategies.
PLOS